Lifeboat Foundation

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.

“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

Continue reading “Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement” »

Today live from Cooper Union, NYC, the June edition of Journal Club is being broadcast on our Facebook page at 13:00 EST / 18:00 UK.

We are discussing the recent paper “Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis.” by Blaso et al.

Tune in today and get involved in the discussion. Journal Club is made possible thanks to the support of our Lifespan Heroes.

Introducing Lifespan Heroes our new campaign.

Here at Lifespan.io we are funding research to help extend healthy human lifespan, supporting nonprofits and companies working to overcome age-related diseases. By becoming a “Lifespan Hero” you can join us in this humanitarian and necessary effort — http://www.lifespan.io/heroes — and help us end age-related diseases for good.

Continue reading “Help Us Crowdfund the Cure for Aging — Be a Lifespan Hero: Join Us!” »

If you are not sure why you should support rejuvenation research, or know people who aren’t, this article explains why rejuvenation would be good for you as an individual.

The reasons why rejuvenation would be good for any given individual should be bleeding obvious. However, you’d be surprised how often people think it all boils down to ‘You’d live forever!’—which by the way is not granted and can be a bit of a controversial concept. The real reasons why rejuvenation would be good for you as an individual are the following.

The elderly of today aren’t exactly famous for their good health, nor for their ability to go about their lives easily and without help in even the simplest tasks. Old people have weaker bodies, weaker immune systems, are prey to a number of horrible diseases and chronic pain, and cannot take care of themselves with the same ease as they did when they were young. Pay attention next time you go downtown. You’ll see elderly people walking slowly and with difficulty, perhaps with the aid of a walker or a cane. They can’t hear well and they can’t see well. Climbing the stairs for them feels like more climbing a mountain. A young person can shake off the flu after a few days of discomfort; an old person may well die of the complications of it, because their weak immune system did not do a very good job. This is, in a nutshell, why young people can take care of themselves and old people end up in hospices or have to be watched over by their families.

Since the moment humans became aware of their existence, they have been haunted by the knowledge that it will inevitably come to an end and the hope to change this unfortunate fate.

This month, during Brain Bar Budapest – Europe’s leading conference on the future – Stephen Cave talked about the four immortality stories we tell ourselves and how they are changing in the context of new scientific discoveries and technological advancements. Stephen Cave spent a decade studying and teaching philosophy, and was awarded his PhD in metaphysics from the University of Cambridge in 2001. He is Executive Director of the Leverhulme Centre for the Future of Intelligence and Senior Research Associate at the University of Cambridge.

Continue reading “The Four Immortality Stories We Tell Ourselves” »

Overpopulation is the most common objection people make to developing rejuvenation biotechnology and potentially increasing healthy human lifespan. We take a look at why that is and if the figures support this concern.

Any discussion of rejuvenation biotechnology almost certainly includes the subject of overpopulation and that objection medical advances that directly address the various processes of aging will lead to an overpopulated world. Such dire predictions are a common theme when advances in medicine that could increase human lifespans are concerned.

Overpopulation is a word that gives the simple fact of population growth a negative connotation. It implies that an increase in the number of people will harm our lives in different ways: it might be famine, scarcity of resources, excessive population density, increased risks of infectious diseases, or harm to the environment.

Continue reading “Will increased lifespans cause overpopulation?” »

Can we live to 1,000? It was outrageous when he said it at ideacity in 2008… and again in 2015. Now he’s back to update us on the incredible progress that has been made toward life extension.

Michael Kramer of Zoomer Radio talks with Aubrey de Grey at ideacity 2017. Aubrey de Grey is an English author and biomedical gerontologist, currently the Chief Science Officer of the SENS Research Foundation. Find out more about ideacity at http://www.ideacity.ca/ideacity-2017/

Continue reading “About Michael Kramer” »

LEAF Director Elena Milova recently attended the International Longevity and Cryopreservation Summit in Madrid and gave a talk about effective advocacy and how we can engage better with the public as advocates for rejuvenation biotechnology.

Her talk touches upon effective message delivery as well as the basic principles of teaching, known as the didactic principles.

Continue reading “Why Life Extension is not Popular with the Public Yet” »

Excellent lightning round questions below the audio. Between Dune and Hitchhikers Guide, Liz is indeed a nerd.

In this episode we talk about aging. It’s a condition that everyone experiences and indeed, one thing is certain: when it comes to aging, our condition is terminal. Our guest today is challenging that and fighting aging head on. We’re speaking with Liz Parrish, the CEO of BioViva, a biotech company dedicated to advancing gene and cell therapies to treat the diseases of aging. We dive into her work and learn about the results of the treatment that she received to slow and maybe even reverse the effects of aging.

Continue reading “Liz Parrish on Therapies to Slow and Reverse the Effects of Aging” »